ScienceDex / Researcher record
Gomperts, Edward
- Hillhurst Biopharmaceuticals, Inc. (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
NIH Funding · FY2023
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2016 | $862,618 | 1 | #8,268 |
| 2017 | $635,033 | 1 | #12,884 |
| 2018 | $168,464 | 1 | #35,444 |
| 2019 | $56,476 | 1 | #42,136 |
| 2021 | $927,639 | 6 | #10,240 |
| 2022 | $480,648 | 2 | #23,816 |
| 2023 | $1,299,472 | 2 | #7,189 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20161 record
- FY20171 record
- FY20181 record
- FY20191 record
- FY20216 records
- FY20222 records
- FY2023 · selected2 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2016 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.
FY2023 award records by amount
NIH award records listing Gomperts, Edward as a PI. Multi-PI records show the full award amount for context.
- 2R44HL131065-05R44Contact PIHBI-002 to Prevent Vaso-Occlusive Crises in Sickle Cell Disease$999.6Kaward amount
- 5R41AI164948-02R41Contact PILow Dose Oral Carbon Monoxide Therapeutic for Virus-Induced Lung Injury$299.9Kaward amount
Award organization
Organizations that administered FY2023 awards listing Gomperts, Edward as a PI.
FY2023 award administered by Hillhurst Biopharmaceuticals, Inc. (CA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2016First NIH AwardHillhurst Biopharmaceuticals, Inc.
- 2016$500K Cumulative Funding
- 2016Entered Top 50% NationallyRanked #8268
- 2017$1M Cumulative Funding
- 2021$2M Cumulative Funding